<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0052">
 <label>52</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Mainolfi</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Karki</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>F</given-names>
   </name>, 
   <name name-style="western">
    <surname>Anderson</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Evolution of a new class of VEGFR-2 inhibitors from scaffold morphing and redesign</article-title>. 
  <source>ACS Med Chem Lett</source>
  <year>2016</year>;
  <volume>7</volume>:
  <fpage>363</fpage>â€“
  <lpage>7</lpage>.
  <pub-id pub-id-type="pmid">27096042</pub-id>
 </mixed-citation>
</ref>
